Mechanisms by which S-albuterol induces human bronchial smooth muscle cell proliferation

International Archives of Allergy and Immunology

Volumn 146, Issue 4, 2008, Pages 321-333

  Ibe, Basil O ^a   Abdallah, May F ^a   Raj, J Usha ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Cell cycle regulators; Cell proliferation; Nuclear factor B; Platelet activating factor receptor; S Albuterol

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEVALBUTEROL; PLATELET DERIVED GROWTH FACTOR; RETINOBLASTOMA PROTEIN; SALBUTAMOL; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ARTICLE; BRONCHUS MUSCLE; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOSOLIC FRACTION; DRUG INHIBITION; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ALBUTEROL; ASTHMA; BLOTTING, WESTERN; BRONCHODILATOR AGENTS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; DRUG SYNERGISM; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-6; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PHOSPHORYLATION; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, G-PROTEIN-COUPLED; RETINOBLASTOMA PROTEIN;

EID: 46849116851     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121466     Document Type: Article

References (39)

1. Martin JG, Duguet MA, Edelman DH: The contribution of the airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease. Eur Respir J 2000;16:349-354.
2. Hirst SJ, Martin JG, Bonacci JV, Chan V, Fixman ED, Hamid QA, Herszberg B, Lavoie J-P, McVicker CG, Moir LM, Nguyen TT, Peng Q, Ramos-Barbón D, Stewart AG: Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol 2004;112:S2-S17.
3. Amrani Y, Panettieri RA: Airway smooth muscle: contraction and beyond. Int J Biochem Cell Biol 2003;35:272-276.
4. Nelson HS: Beta-adrenergic bronchodilators. N Engl J Med 1995;333:499-506.
5. Handley DA, Anderson AJ, Koester J, Snider ME: New millennium bronchodilators for asthma: single isomer beta agonists. Curr Opin Pulm Med 2000;6:43-49.
6. Ramsey CM, Cowan J, Flannery E, McLachlan C, Taylor DR: Bronchoprotective and bronchodilator effect of single doses of S-salbutamol, R-salbutamol and racemic salbutamol in patients with bronchial asthma. Eur J Clin Pharmacol 1999;55:353-359.
7. Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC: Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993;342:833-837.
8. Nelson HS, Bensch G, Pleskow WW, DiSantostefano R, DeGraw S, Reasner DS, Rollins TE, Rubin PD: Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998;102:943-952.
9. Mitra S, Ugur M, Ugor O, Goodman HM, McCullough JR, Yamaguchi H: S-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C dependent mechanism in airway smooth muscle. Mol Pharmacol 1998;53:347-354.
10. Hishiko K, Morley J: Exacerbation of airway hyperreactivity by (+/-)salbutamol in sensitized guinea pigs. Jpn J Pharmacol 1993;63:159-163.
11. Boulton D, Fawcett JP: Enantioselective disposition of salbutamol in man following oral and intravenous administration. Br J Clin Pharmacol 1996;41:35-40.
12. Dhand R, Goode M, Reid R, Fink JB, Fahey PJ, Tobin MJ: Preferential pulmonary retension of S-albuterol after inhalation of racemic albuterol. Am J Respir Crit Care Med 1999;160:1136-1141.
13. Ibe BO, Portugal AM, Raj JU: Levalbuterol inhibits human airway smooth muscle cell proliferation: Therapeutic implications in the management of asthma. Int Arch Allergy Immunol 2006;139:225-236.
14. Dutta EJ, Li JT: Beta agonists. Med Clin North Am 2002;86:991-1008.
15. Yamaguchi H, McCullough J: S-Albuterol exacerbates calcium responses to cabachol in airway smooth muscle cells. Clin Rev Allergy Immunol 1996;14:47-55.
16. Amrani Y, Tliba O, Choubey D, Huang C-D, Krymskaya VP, Eszterhas A, Lazaar AL, Panettieri RA Jr: IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway. Am J Physiol Lung Cell Mol Physiol 2003;84:L1063-L1071.
17. Berthet C, Kaldis P: Cdk2 and Cdk4 cooperatively control the expression of Cdc2. Cell Div 2006;1:1-6.
18. Berthet C, Klarmann KD, Hilton MB, Suh HC, Keller JR, Kiyokawa H, Kaldis P: Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation. Dev Cell 2006;10:563-573.
19. Tacconelli A, Farina AR, Cappabianca L, DeSantis G, Tessitore A, Vetuschi A, Sferra R, Rucci N, Argenti I, Screpant I, Gulino A, Mackay AR: TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 2004;6:347-360.
20. Bassères DS, Baldwin AS: Nuclear factor-κB and inhibitor κB kinase pathways in oncogenic initiation and progression. Oncogene 2006;25:6817-6830.
21. Perkins ND: Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 2006;25:6717-6730.
22. Dutta J, Fan Y, Gupta N, Fan G, Gélinas C: Current insights into the regulation of programmed cell death by NF-κB. Oncogene 2006;25:6800-6816.
23. Whiteside ST, Epinat JC, Rice NR, Israel AI: Kappa B epsilon, a novel member of the I kappa B family, control RelA and cRel NF-kappa B activity. EMBO J 1997;16:1413-1426.
24. Agrawal DK, Ariyarathna A, Kelbe PW: S-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells. J Allergy Clin Immunol 2004;113:303-310.
25. Nagy I, Caelers A, Monge A, Bonabi S, Huber AM, Bodmer D: NF-kappaB-dependent apoptotic hair cell death in the auditory system. Audiol Neurootol 2007;12:209-220.
26. Gao N, Flynn DC, Zhang Z, Zhong X-S, Walker V, Liu KJ, Shi X, Jiang B-H: G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol 2004;287:C281-C291.
27. Noseda M, Chang L, Mclean G, Grim JE, Clurman BE, Smith LL, Karsan A: Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Mol Cell Biol 2004;24:8813-8822.
28. Bartkova J, Lukas C, Sorensen CS, Meyts ERD, Skakkebaek NE, Lukas J, Bartek J: Deregulation of the RB pathway in human testicular germ cell tumours. J Pathol 2003;200:149-156.
29. Malumbres M, Ortega S, Barbacid M: Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors. Biol Chem 2000;381:827-838.
30. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA: Effects of an RB mutation in the mouse. Nature 1992;359:295-300.
31. Shah SA, Potter MW, Ricciardi R, Perugini RA, Callery MP: FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation. J Surg Res 2001;97:123-130.
32. Aleem E, Berthet C, Kaldis P: Cdk2 as a matter of S phase entry: fact or fake? Cell Cycle 2004;3:35-37.
33. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G: Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 2003;22:1313-1314.
34. Cui R, Tieu B, Recinos A, Tilton RG, Brasier AR: RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor κB/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Circ Res 2006;99:723-730.
35. Oliver BG, Johnston SL, Baraket M, Burgess JK, King NJC, Roth M, Lim S, Black JL: Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection. Respir Res 2006;7:71.
36. Baouz S, Giron-Michel J, Azzarone B, Giuliani M, Cagnoni F, Olsson S, Testi R, Gabbiani G, Canonica GW: Lung myofibroblasts as targets of salmeterol and fluticasone: inhibition of α-SMA and NF-κB. Int Immunol 2005;17:1473-1481.
37. Gaumond F, Fortin D, Stankova J, Rola-Pleszczyski M: Differential signaling pathways in platelet-activating factor-induced proliferation and interleukin-6 production by rat vascular smooth muscle cells. J Cardiovasc Pharmacol 1997;30:169-175.
38. Page CP, Paul W, Dewar A, Wood L, Basran GS, Morley J: PAF-acether: a putative mediator of asthma and inflammation. Agents Actions Suppl 1983;13:177-183.
39. Gabrijelcic J, Casas A, Rabinovich RA, Roca J, Barbera JA, Chung KF, Rodriquez-Roisin R: Formoterol protects against platelet-activating factor-induced effects in asthma. Eur Respir J 2004;23:71-75.